ALKEM.NS
ALKEM.NS
INE540L01014
ALKEM LABORATORIES LTD.
Loading chart...

Company Profile

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti – infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.

Related stocks

GLENMARK.NS
GLENMARK.NS • India
GLENMARK PHARMACEUTICALS
2,293 INR
6.69B USD 1Y +13.6%
ABBOTINDIA.NS
ABBOTINDIA.NS • India
ABBOTT INDIA LIMITED
26,000 INR
5.71B USD 1Y -14.5%
AJANTPHARM.NS
AJANTPHARM.NS • India
AJANTA PHARMA LIMITED
3,410.1 INR
4.4B USD 1Y +40.8%
DRREDDY.NS
DRREDDY.NS • India
DR. REDDY S LABORATORIES
1,197 INR
10.3B USD 1Y -3.9%
RDY
RDY • India
Dr. Reddy's Laboratories Ltd
12.48 USD
10.4B USD 1Y -12.8%
LUPIN.NS
LUPIN.NS • India
LUPIN LIMITED
1,956.5 INR
9.24B USD 1Y -0.1%
LAURUSLABS.NS
LAURUSLABS.NS • India
LAURUS LABS LIMITED
2,036.6 INR
11.37B USD 1Y +135.4%
IPCALAB.NS
IPCALAB.NS • India
IPCA LABORATORIES LTD
1,915.4 INR
5.02B USD 1Y +43%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
23.2% p.a.
Max Drawdown (5Y)
-28.3%
Sharpe Ratio (5Y)
0.15
Beta Factor
0.29
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende